Bausch Health Cos., Inc. (BHC.TO)
8.64
+0.04
(+0.47%)
CAD |
TSX |
Oct 09, 16:00
Bausch Health Cos. Gross Profit Margin (Quarterly) : 65.04% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.04% |
| March 31, 2026 | 61.21% |
| December 31, 2025 | 63.02% |
| September 30, 2025 | 62.59% |
| June 30, 2025 | 59.68% |
| March 31, 2025 | 57.64% |
| December 31, 2024 | 61.47% |
| September 30, 2024 | 61.35% |
| June 30, 2024 | 58.84% |
| March 31, 2024 | 57.55% |
| December 31, 2023 | 59.01% |
| September 30, 2023 | 60.86% |
| June 30, 2023 | 57.64% |
| March 31, 2023 | 56.02% |
| December 31, 2022 | 56.00% |
| September 30, 2022 | 57.28% |
| June 30, 2022 | 55.31% |
| March 31, 2022 | 55.11% |
| December 31, 2021 | 56.92% |
| September 30, 2021 | 56.42% |
| June 30, 2021 | 53.71% |
| March 31, 2021 | 54.07% |
| December 31, 2020 | 53.59% |
| September 30, 2020 | 54.12% |
| June 30, 2020 | 44.05% |
| Date | Value |
|---|---|
| March 31, 2020 | 52.53% |
| December 31, 2019 | 51.44% |
| September 30, 2019 | 52.06% |
| June 30, 2019 | 49.72% |
| March 31, 2019 | 49.11% |
| December 31, 2018 | 47.95% |
| September 30, 2018 | 41.95% |
| June 30, 2018 | 37.26% |
| March 31, 2018 | 34.04% |
| December 31, 2017 | 34.26% |
| September 30, 2017 | 40.69% |
| June 30, 2017 | 43.17% |
| March 31, 2017 | 41.63% |
| December 31, 2016 | 44.99% |
| September 30, 2016 | 46.64% |
| June 30, 2016 | 45.03% |
| March 31, 2016 | 44.16% |
| December 31, 2015 | 48.80% |
| September 30, 2015 | 52.37% |
| June 30, 2015 | 53.50% |
| March 31, 2015 | 59.11% |
| December 31, 2014 | 57.32% |
| September 30, 2014 | 55.18% |
| June 30, 2014 | 53.40% |
| March 31, 2014 | 53.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 42.90% |
| Cipher Pharmaceuticals, Inc. | 65.58% |
| BioSyent, Inc. | 65.02% |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | 38.94% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -4.16% |
| Return on Invested Capital | -5.17% |
| Profit Margin (Quarterly) | 9.12% |
| Operating Margin (Quarterly) | 27.17% |
| Return on Net Operating Assets | -5.07% |